Cover Image
市場調查報告書

人工心臟瓣膜:開發平台分析

Prosthetic Heart Valves - Pipeline Review, 2015

出版商 GlobalData 商品編碼 213207
出版日期 內容資訊 英文 309 Pages
訂單完成後即時交付
價格
Back to Top
人工心臟瓣膜:開發平台分析 Prosthetic Heart Valves - Pipeline Review, 2015
出版日期: 2015年04月28日 內容資訊: 英文 309 Pages
簡介

本報告提供全球各國現在開發、臨床實驗中的人工心臟瓣膜的開發中產品相關分析、整體開發的進展,及企業間、地區間比較、主要企業及各公司的開發中產品的概要的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 人工心臟瓣膜概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:各認證階段
  • 開發中產品:(估計) 各認證時期

第4章 正在開發的開發中產品:各企業

  • 人工心臟瓣膜的開發企業:開發中產品,各開發階段
  • 人工心臟瓣膜:開發中產品,各開發階段

第5章 企業、產品概要

  • Aegis Surgical Limited
    • 開發中產品及現在進行中的臨床實驗概要
  • AorTech International plc
  • Apica Cardiovascular Limited
  • Boston Children's Hospital
  • Boston Scientific Corporation
  • Braile Biomedica Ltda.
  • Caisson Interventional, LLC
  • Cardiac Dimensions, Inc.
  • CardiAQ Valve Technologies, Inc.
  • Cardio3 BioSciences SA
  • Cephea Valve Technologies, Inc.
  • Clemson University
  • Colibri Heart Valve, LLC
  • CorMatrix Cardiovascular, Inc.
  • CryoLife, Inc.
  • Cytograft Tissue Engineering, Inc.
  • Direct Flow Medical, Inc.
  • Dura Biotech
  • Edwards Lifesciences Corporation
  • Emory University
  • HighLife SAS
  • HLT, Inc.
  • Innovia LLC
  • JenaValve Technology GmbH
  • Leman Cardiovascular
  • Mayo Clinic
  • Medi-Line S.A.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Micro Interventional Devices, Inc.
  • MicroPort Scientific Corporation
  • Mitralix Ltd.
  • MitrAssist Ltd.
  • Mitricares
  • NaviGate Cardiac Structures, Inc.
  • Neovasc Inc.
  • Peca Labs, Inc.
  • PolyNova Cardiovascular LLC
  • RegenaGraft
  • Revivicor, Inc.
  • SAS Cormove
  • Scientific and Production Center Amphion, LLC
  • Sorin S.p.A.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • St. Jude Medical, Inc.
  • Stellenbosch University
  • Strait Access Technologies (Pty) Ltd
  • Symetis AG Company
  • Tendyne Medical, Inc.
  • The Tel Aviv Sourasky Medical Center
  • Thubrikar Aortic Valve, Inc.
  • Tissue Regenix Ltd
  • Transcatheter Technologies GmbH
  • Twelve, Inc
  • UMC Utrecht Holding BV
  • University College London
  • University of California, Irvine
  • University of Pennsylvania
  • Valtech Cardio Ltd.
  • ValveXchange, Inc.
  • VueKlar Cardiovascular Ltd.
  • Xeltis AG

第6章 近幾年的市場趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0006EPD

GlobalData's Medical Devices sector report, "Prosthetic Heart Valves - Pipeline Review, 2015" provides an overview of Prosthetic Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key prosthetic heart valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Prosthetic Heart Valves products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Prosthetic Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Prosthetic Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Prosthetic Heart Valves Overview

3. Products under Development

  • 3.1. Prosthetic Heart Valves - Pipeline Products by Stage of Development
  • 3.2. Prosthetic Heart Valves - Pipeline Products by Segment
  • 3.3. Prosthetic Heart Valves - Pipeline Products by Territory
  • 3.4. Prosthetic Heart Valves - Pipeline Products by Regulatory Path
  • 3.5. Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date
  • 3.6. Prosthetic Heart Valves - Ongoing Clinical Trials

4. Prosthetic Heart Valves - Pipeline Products under Development by Companies

  • 4.1. Prosthetic Heart Valves Companies - Pipeline Products by Stage of Development
  • 4.2. Prosthetic Heart Valves - Pipeline Products by Stage of Development

5. Prosthetic Heart Valves Companies and Product Overview

  • 5.1. Aegis Surgical Limited Company Overview
    • 5.1.1. Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. AorTech International plc Company Overview
    • 5.2.1. AorTech International plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Apica Cardiovascular Limited Company Overview
    • 5.3.1. Apica Cardiovascular Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Boston Children's Hospital Company Overview
    • 5.4.1. Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Boston Scientific Corporation Company Overview
    • 5.5.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Braile Biomedica Ltda. Company Overview
    • 5.6.1. Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Caisson Interventional, LLC Company Overview
    • 5.7.1. Caisson Interventional, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Cardiac Dimensions, Inc. Company Overview
    • 5.8.1. Cardiac Dimensions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. CardiAQ Valve Technologies, Inc. Company Overview
    • 5.9.1. CardiAQ Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Cardio3 BioSciences SA Company Overview
    • 5.10.1. Cardio3 BioSciences SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Cephea Valve Technologies, Inc. Company Overview
    • 5.11.1. Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Clemson University Company Overview
    • 5.12.1. Clemson University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Colibri Heart Valve, LLC Company Overview
    • 5.13.1. Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. CorMatrix Cardiovascular, Inc. Company Overview
    • 5.14.1. CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. CryoLife, Inc. Company Overview
    • 5.15.1. CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Cytograft Tissue Engineering, Inc. Company Overview
    • 5.16.1. Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Direct Flow Medical, Inc. Company Overview
    • 5.17.1. Direct Flow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Dura Biotech Company Overview
    • 5.18.1. Dura Biotech Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Edwards Lifesciences Corporation Company Overview
    • 5.19.1. Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Emory University Company Overview
    • 5.20.1. Emory University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. HighLife SAS Company Overview
    • 5.21.1. HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. HLT, Inc. Company Overview
    • 5.22.1. HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Innovia LLC Company Overview
    • 5.23.1. Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. JenaValve Technology GmbH Company Overview
    • 5.24.1. JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Leman Cardiovascular Company Overview
    • 5.25.1. Leman Cardiovascular Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Mayo Clinic Company Overview
    • 5.26.1. Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Medi-Line S.A. Company Overview
    • 5.27.1. Medi-Line S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Medtronic plc Company Overview
    • 5.28.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Meril Life Sciences Pvt. Ltd. Company Overview
    • 5.29.1. Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Micro Interventional Devices, Inc. Company Overview
    • 5.30.1. Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. MicroPort Scientific Corporation Company Overview
    • 5.31.1. MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Mitralix Ltd. Company Overview
    • 5.32.1. Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. MitrAssist Ltd. Company Overview
    • 5.33.1. MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Mitricares Company Overview
    • 5.34.1. Mitricares Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. NaviGate Cardiac Structures, Inc. Company Overview
    • 5.35.1. NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Neovasc Inc. Company Overview
    • 5.36.1. Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Peca Labs, Inc. Company Overview
    • 5.37.1. Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. PolyNova Cardiovascular LLC Company Overview
    • 5.38.1. PolyNova Cardiovascular LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. RegenaGraft Company Overview
    • 5.39.1. RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Revivicor, Inc. Company Overview
    • 5.40.1. Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. SAS Cormove Company Overview
    • 5.41.1. SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. Scientific and Production Center Amphion, LLC Company Overview
    • 5.42.1. Scientific and Production Center Amphion, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. Sorin S.p.A. Company Overview
    • 5.43.1. Sorin S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.44.1. Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. St. Jude Medical, Inc. Company Overview
    • 5.45.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. Stellenbosch University Company Overview
    • 5.46.1. Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. Strait Access Technologies (Pty) Ltd Company Overview
    • 5.47.1. Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. Symetis AG Company Overview
    • 5.48.1. Symetis AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. Tendyne Medical, Inc. Company Overview
    • 5.49.1. Tendyne Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. The Tel Aviv Sourasky Medical Center Company Overview
    • 5.50.1. The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Thubrikar Aortic Valve, Inc. Company Overview
    • 5.51.1. Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Tissue Regenix Ltd Company Overview
    • 5.52.1. Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. Transcatheter Technologies GmbH Company Overview
    • 5.53.1. Transcatheter Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. Twelve, Inc Company Overview
    • 5.54.1. Twelve, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. UMC Utrecht Holding BV Company Overview
    • 5.55.1. UMC Utrecht Holding BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. University College London Company Overview
    • 5.56.1. University College London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. University of California, Irvine Company Overview
    • 5.57.1. University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. University of Pennsylvania Company Overview
    • 5.58.1. University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59. Valtech Cardio Ltd. Company Overview
    • 5.59.1. Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60. ValveXchange, Inc. Company Overview
    • 5.60.1. ValveXchange, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61. VueKlar Cardiovascular Ltd. Company Overview
    • 5.61.1. VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.62. Xeltis AG Company Overview
    • 5.62.1. Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview

6. Prosthetic Heart Valves- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Prosthetic Heart Valves - Pipeline Products by Stage of Development
  • Table 2: Prosthetic Heart Valves - Pipeline Products by Segment
  • Table 3: Prosthetic Heart Valves - Pipeline Products by Territory
  • Table 4: Prosthetic Heart Valves - Pipeline Products by Regulatory Path
  • Table 5: Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date
  • Table 6: Prosthetic Heart Valves - Ongoing Clinical Trials
  • Table 7: Prosthetic Heart Valves Companies - Pipeline Products by Stage of Development
  • Table 8: Prosthetic Heart Valves - Pipeline Products by Stage of Development
  • Table 9: Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: pTAo-TAVR - Product Status
  • Table 11: pTAo-TAVR - Product Description
  • Table 12: AorTech International plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: AorTech Polymer Valve - Product Status
  • Table 14: AorTech Polymer Valve - Product Description
  • Table 15: Apica Cardiovascular Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Next Generation Device For TAVI - Product Status
  • Table 17: Next Generation Device For TAVI - Product Description
  • Table 18: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Two Piece Replacement Heart Valve Apparatus - Product Status
  • Table 20: Two Piece Replacement Heart Valve Apparatus - Product Description
  • Table 21: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: 21 mm Lotus Valve System - Product Status
  • Table 23: 21 mm Lotus Valve System - Product Description
  • Table 24: 23 mm Lotus Valve System - Product Status
  • Table 25: 23 mm Lotus Valve System - Product Description
  • Table 26: 25 mm Lotus Valve System - Product Status
  • Table 27: 25 mm Lotus Valve System - Product Description
  • Table 28: 27 mm Lotus Valve System - Product Status
  • Table 29: 27 mm Lotus Valve System - Product Description
  • Table 30: 29 mm Lotus Valve System - Product Status
  • Table 31: 29 mm Lotus Valve System - Product Description
  • Table 32: Boston Scientific Corporation - Ongoing Clinical Trials Overview
  • Table 33: 23 mm Lotus Valve System - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System (REPRISE I)
  • Table 34: 23 mm Lotus Valve System - REPRISE II: Repositionable Percutaneous Replacement Of Stenotic Aortic Valve Through Implantation Of Lotus Valve System: Evaluation Of Safety And Performance
  • Table 35: 23 mm Lotus Valve System - RESPOND: Repositionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes
  • Table 36: 27 mm Lotus Valve System - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve With the Next Generation Delivery System: REPRISE NGDS
  • Table 37: 25 mm Lotus Valve System - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation (REPRISE III)
  • Table 38: Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Inovare Valve - Product Status
  • Table 40: Inovare Valve - Product Description
  • Table 41: Caisson Interventional, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Caisson TMVR - Product Status
  • Table 43: Caisson TMVR - Product Description
  • Table 44: Cardiac Dimensions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: CARILLON Mitral Contour System - Product Status
  • Table 46: CARILLON Mitral Contour System - Product Description
  • Table 47: Enhanced CARILLON Mitral Contour System - Product Status
  • Table 48: Enhanced CARILLON Mitral Contour System - Product Description
  • Table 49: Cardiac Dimensions, Inc. - Ongoing Clinical Trials Overview
  • Table 50: CARILLON Mitral Contour System - COMPETENT Pilot Study of the CARILLON Mitral Contour System for Treatment of Functional Mitral Regurgitation
  • Table 51: CARILLON Mitral Contour System - Evaluation of Safety and Efficacy of The CARILLON Device
  • Table 52: CARILLON Mitral Contour System - Safety and Efficacy of the CARILLON Mitral Contour System in Reducing Functional Mitral Regurgitation (FMR) Associated with Heart Failure: The REDUCE FMR Trial
  • Table 53: CardiAQ Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Second Generation Transapical Transcatheter Mitral Valve - Product Status
  • Table 55: Second Generation Transapical Transcatheter Mitral Valve - Product Description
  • Table 56: Second Generation Transfemoral Transcatheter Mitral Valve - Product Status
  • Table 57: Second Generation Transfemoral Transcatheter Mitral Valve - Product Description
  • Table 58: Transcatheter Mitral Valve Implantation System - Product Status
  • Table 59: Transcatheter Mitral Valve Implantation System - Product Description
  • Table 60: CardiAQ Valve Technologies, Inc. - Ongoing Clinical Trials Overview
  • Table 61: Second Generation Transapical Transcatheter Mitral Valve - Early Feasibility Study Using the CardiAQ Second-generation Transfemoral (TF) and Transapical (TA) Transcatheter Mitral Valve Implantation (TMVI) Systems
  • Table 62: Second Generation Transfemoral Transcatheter Mitral Valve - Early Feasibility Study Using the CardiAQ Second-generation Transfemoral (TF) and Transapical (TA) Transcatheter Mitral Valve Implantation (TMVI) Systems
  • Table 63: Cardio3 BioSciences SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: Mitral Valve Neo-chordae - Product Status
  • Table 65: Mitral Valve Neo-chordae - Product Description
  • Table 66: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Mitral Valve Replacement Device - Product Status
  • Table 68: Mitral Valve Replacement Device - Product Description
  • Table 69: Clemson University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: Mechanical Heart Valve - Product Status
  • Table 71: Mechanical Heart Valve - Product Description
  • Table 72: Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Colibri Aortic Heart Valve - 24mm - Product Status
  • Table 74: Colibri Aortic Heart Valve - 24mm - Product Description
  • Table 75: Colibri Aortic Heart Valve - 21mm - Product Status
  • Table 76: Colibri Aortic Heart Valve - 21mm - Product Description
  • Table 77: Colibri Aortic Heart Valve - 27mm - Product Status
  • Table 78: Colibri Aortic Heart Valve - 27mm - Product Description
  • Table 79: Colibri TAVI Device - Product Status
  • Table 80: Colibri TAVI Device - Product Description
  • Table 81: Custom Delivery System - Product Status
  • Table 82: Custom Delivery System - Product Description
  • Table 83: Delta Aortic Heart Valve - Product Status
  • Table 84: Delta Aortic Heart Valve - Product Description
  • Table 85: Pulmonary Valve - Product Status
  • Table 86: Pulmonary Valve - Product Description
  • Table 87: Sutureless Surgical Aortic Valve - Product Status
  • Table 88: Sutureless Surgical Aortic Valve - Product Description
  • Table 89: Colibri Heart Valve, LLC - Ongoing Clinical Trials Overview
  • Table 90: Colibri TAVI Device - Colibri TAVI System, First Ready-to-Use Transcatheter Heart Valve System: A Prospective, Multicenter, Non-Randomized, Investigational Study
  • Table 91: CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: CorMatrix ECM - Heart Valve Repair - Product Status
  • Table 93: CorMatrix ECM - Heart Valve Repair - Product Description
  • Table 94: CorMatrix ECM - Heart Valve Replacement - Product Status
  • Table 95: CorMatrix ECM - Heart Valve Replacement - Product Description
  • Table 96: CorMatrix ECM Tricuspid Heart Valve - Product Status
  • Table 97: CorMatrix ECM Tricuspid Heart Valve - Product Description
  • Table 98: Pediatric Prosthetic Trileaflet Valve - Product Status
  • Table 99: Pediatric Prosthetic Trileaflet Valve - Product Description
  • Table 100: CorMatrix Cardiovascular, Inc. - Ongoing Clinical Trials Overview
  • Table 101: CorMatrix ECM Tricuspid Heart Valve - Early Feasibility and Investigational Device Exemption Study of CorMatrix ECM Tricuspid Heart Valve
  • Table 102: CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: CryoValve SGAV - Product Status
  • Table 104: CryoValve SGAV - Product Description
  • Table 105: Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 106: Cytograft Valve - Product Status
  • Table 107: Cytograft Valve - Product Description
  • Table 108: Direct Flow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: 18F Direct Flow Medical Transcatheter Aortic Valve System - Product Status
  • Table 110: 18F Direct Flow Medical Transcatheter Aortic Valve System - Product Description
  • Table 111: 23mm Direct Flow Medical Transcatheter Aortic Valve System - Product Status
  • Table 112: 23mm Direct Flow Medical Transcatheter Aortic Valve System - Product Description
  • Table 113: Direct Flow Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 114: 18F Direct Flow Medical Transcatheter Aortic Valve System - A Registry To Evaluate The Direct Flow Medical Transcatheter Aortic Valve System For The Treatment Of Patients With Severe Aortic Stenosis
  • Table 115: 18F Direct Flow Medical Transcatheter Aortic Valve System - Direct Flow Medical Transcatheter Aortic Valve System Demonstrates Trial Outcomes in SALUS Trial
  • Table 116: 18F Direct Flow Medical Transcatheter Aortic Valve System - The Direct Flow Medical Transcatheter Aortic Valve Replacement System a US Pivotal Trial
  • Table 117: 18F Direct Flow Medical Transcatheter Aortic Valve System - The Direct Flow Medical TranScatheter Aortic Valve RepLacement System US Feasibility Trial
  • Table 118: Dura Biotech Pipeline Products & Ongoing Clinical Trials Overview
  • Table 119: Dura Heart Valve - Product Status
  • Table 120: Dura Heart Valve - Product Description
  • Table 121: LowPro Valve - Product Status
  • Table 122: LowPro Valve - Product Description
  • Table 123: Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 124: Edwards CENTERA Valve - Product Status
  • Table 125: Edwards CENTERA Valve - Product Description
  • Table 126: Edwards SAPIEN 3 Valve - Product Status
  • Table 127: Edwards SAPIEN 3 Valve - Product Description
  • Table 128: Edwards SAPIEN Pulmonic Transcatheter Heart Valve - Product Status
  • Table 129: Edwards SAPIEN Pulmonic Transcatheter Heart Valve - Product Description
  • Table 130: Edwards SAPIEN XT Valve - 20mm - Product Status
  • Table 131: Edwards SAPIEN XT Valve - 20mm - Product Description
  • Table 132: FORTIS Mitral Transcatheter Heart Valve - Product Status
  • Table 133: FORTIS Mitral Transcatheter Heart Valve - Product Description
  • Table 134: GLX Aortic Conduit - Product Status
  • Table 135: GLX Aortic Conduit - Product Description
  • Table 136: INTUITY ELITE - Product Status
  • Table 137: INTUITY ELITE - Product Description
  • Table 138: INTUITY Valve System - Product Status
  • Table 139: INTUITY Valve System - Product Description
  • Table 140: Magna EASE Surgical Valve With GLX - Product Status
  • Table 141: Magna EASE Surgical Valve With GLX - Product Description
  • Table 142: Next Gen CENTERA - Product Status
  • Table 143: Next Gen CENTERA - Product Description
  • Table 144: Next Gen SAPIEN - Product Status
  • Table 145: Next Gen SAPIEN - Product Description
  • Table 146: SAPIEN XT - Valve-In-Valve Indication - Product Status
  • Table 147: SAPIEN XT - Valve-In-Valve Indication - Product Description
  • Table 148: ZETA Platform - Product Status
  • Table 149: ZETA Platform - Product Description
  • Table 150: Edwards Lifesciences Corporation - Ongoing Clinical Trials Overview
  • Table 151: INTUITY Valve System - Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement
  • Table 152: INTUITY Valve System - Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve

List of Figures

  • Figure 1: Prosthetic Heart Valves - Pipeline Products by Stage of Development
  • Figure 2: Prosthetic Heart Valves - Pipeline Products by Segment
  • Figure 3: Prosthetic Heart Valves - Pipeline Products by Territory
  • Figure 4: Prosthetic Heart Valves - Pipeline Products by Regulatory Path
  • Figure 5: Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date
  • Figure 6: Prosthetic Heart Valves - Ongoing Clinical Trials
Back to Top